Over the past year ASCIA has updated and developed more than 24 online resources and 10 e-training courses to assist in the emergency treatment and management of anaphylaxis (severe allergic reactions).

Each year ASCIA online anaphylaxis resources are viewed more than 500,000 times and there are more than 100,000 registrations for the ASCIA anaphylaxis e-training courses.

The latest resources to be updated are ASCIA anaphylaxis checklists and e-training courses for prescribers (doctors and nurse practitioners), pharmacists and patients/carers, which now include information about two brands of adrenaline injectors, EpiPen^® and Anapen^®:

• EpiPen^® (300 mcg) and EpiPen^® Jr (150 mcg) are available in Australia on the PBS, and in New Zealand.
• Anapen^® 500, Anapen^® 300 and Anapen^® 150 are available in Australia on the PBS.

Adrenaline injectors are prescribed as follows:

• 150 mcg devices for children weighing 7.5 to 20kg.
• 300 mcg devices for children weighing over 20kg and adults, including pregnant women.
• 500 mcg or 300 mcg devices for children weighing over 50kg and adults, including pregnant women.

ASCIA has developed checklists to assist health professionals and patients/carers in the following ways:

• Anaphylaxis Checklist for Adrenaline Prescribers - Developed to assist doctors and nurse practitioners who prescribe adrenaline injectors for patients who are at risk of anaphylaxis.
• Anaphylaxis Checklist for Pharmacists - Developed to assist pharmacists who dispense adrenaline injectors to patients who are at risk of anaphylaxis.
• Anaphylaxis Checklist for Patients* - Developed to assist patients who are at risk of anaphylaxis, and their carers.
• Anaphylaxis Checklist for Transitioning from Paediatric to Adult Care* - Developed to assist young adults understand their allergies and learn to look after their health independently to make the transition from paediatric to adult medical care easier.
• Anaphylaxis Checklist for Travelling with Allergy, Asthma or Anaphylaxis - Developed to assist people at risk of anaphylaxis, who need to carry adrenaline when travelling.

Updated ASCIA anaphylaxis resources and e-training courses are available at www.allergy.org.au/anaphylaxis

ASCIA anaphylaxis education and training resources have been developed to assist with:

• Prevention of anaphylaxis, including strategies to avoid exposure to allergens.
• Emergency treatment of anaphylaxis, to prevent unnecessary death or disability.
• Providing accessible, consistent and evidence-based information from a reliable source.

*ReadSpeaker is available on the ASCIA webpages for patients, consumers and carers, to improve access for people with:

• Vision impairment, limited reading ability or learning disabilities, by allowing text to speech (TTS).
• Non-English speaking backgrounds - information can be translated into 20 different languages by highlighting the text and selecting 'translate’.

ASCIA will continue to review and update anaphylaxis resources and e-training courses as new information is available.